Veraxa Biotech Holding AG (VRXA) Equity Ratio (2024 - 2025)
Veraxa Biotech Holding AG (VRXA) posted Equity Ratio of 1.22 for Q4 2025, down 46320.41% on a QoQ basis from 0.0 in Q4 2024, and down 46320.41% YoY from N/an in Q4 2024.
Veraxa Biotech Holding AG (VRXA) Equity Ratio (2024 - 2025) Analysis & Trends
Veraxa Biotech Holding AG (VRXA) has reported Equity Ratio for 2 consecutive years, with 1.22 the latest figure, recorded in Q4 2025.
- For the quarter ending Q4 2025, Equity Ratio fell 46320.41% year-over-year to 1.22; the trailing twelve-month figure through Dec 2025 stood at 1.22 (down 46320.41% YoY), and the FY2025 full-year result was 1.22, down 46320.41% from the prior year.
- Equity Ratio eased to 1.22 in Q4 2025 per VRXA's latest filing, from 0.0 in the prior quarter.
- In the past five years, Equity Ratio ranged from a high of 0.0 in Q4 2024 to a low of 1.22 in Q4 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -1.22 |
| Dec 31, 2024 | 0.00 |